<DOC>
	<DOCNO>NCT01633593</DOCNO>
	<brief_summary>Nowadays feature diagnosis delirium : 1 . Disturbance consciousness ( i.e . reduce clarity environment awareness ) reduce ability focus , sustain shift attention ; 2 . A change cognition ( memory deficit , disorientation , language disturbance ) development perceptual disturbance well account pre-existing evolving dementia ; 3 . The disturbance develop short period time ( usually hour day ) severity fluctuates course day ; 4 . There evidence history , physical examination , laboratory finding disorder cause direct physiological consequence general medical condition , substance intoxication substance withdrawal . Treatment underlie clinical disease important remit delirium . However , procedures alone enough remit delirium early prevent sequel . There need specific faster strategy treat delirium . The investigator want test hypothesis Anticholinesterase Inhibitor ( donepezil ) reduce duration delirium .</brief_summary>
	<brief_title>Treatment Delirium Elderly With Donepezil : Double-blind , Randomized , Placebo-controlled Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Over 60 year old Delirium accord CAMICU ( Confusion Assessment Method Intensive Care Unit ) inform consent ( legal representative ) unable swallow pill previous allergy donepezil Atrioventricular block 2nd 3nd degree</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>